tirzepatide obstructive sleep apnea ✨ FDA Approves for Apnea! ✨ A breakthrough in treating moderate to severe OSA—tirzepatide (Zepbound) is the first-ever medication approved by the FDA for this condition in adults with Tirzepatide is moving beyond weight

GLP-1s not tied to suicide, self-harm According to Peter Ueda, MD, PhD , an assistant professor at Karolinska Institute in Sweden, and colleagues, the effect of GLP-1 receptor agonists on suicidality is plausible becausre the drugs have been shown to cross the blood-brain barrier. However, they also pointed out how some have hypothesized that GLP-1 receptor agonists could protect against mental illness like depression

In particular, people age 65 and older may be susceptible to distinct risks including muscle mass loss when taking GLP-1s and similar drugs

The dual mechanism of BPC-157s vascular stabilization and TB-500s migratory promotion makes it an attractive candidate in vascularization studies

Addressing Loose Skin and Body Image Significant weight loss can lead to loose or sagging skin, which may be a concern for some individuals

The primary cause is the musculoskeletal adjustment to changing body weight, though inflammation from dehydration and nutrient deficiencies can amplify the sensation